122 related articles for article (PubMed ID: 35230712)
1. Incidence of Antiseizure Medication-Induced Severe Cutaneous Adverse Reactions in Malaysia.
Fong SL; Lim KS; Hariraj V; Lee SC; Wo WK; Ramli A; Ho JH; Lai PSM; Ng WL
J Clin Pharmacol; 2022 Aug; 62(8):983-991. PubMed ID: 35230712
[TBL] [Abstract][Full Text] [Related]
2. Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in Korea.
Chung SJ; Ahn KM; Oh JH; Shim JS; Park HW
Epilepsia; 2021 Jan; 62(1):250-257. PubMed ID: 33188522
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment.
Tensini TS; Von Glehn CQC; Bettinotti MP; Iglehart B; de Paola L; Lohr A; Rodrigues M; Tensini FS; Braatz VL; Silvado CES
Epileptic Disord; 2021 Jun; 23(3):466-475. PubMed ID: 34080983
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Ding WY; Lee CK; Choon SE
Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
[TBL] [Abstract][Full Text] [Related]
5. Incidence of allopurinol-induced severe cutaneous adverse drug reaction in Malaysia.
Ng WL; Lim KS; Hariraj V; Lee SC; Wo WK; Ramli A; Lai PSM; Fong SL; Lim JR
Br J Clin Pharmacol; 2022 Aug; 88(8):3782-3788. PubMed ID: 35318720
[TBL] [Abstract][Full Text] [Related]
6. HLA alleles and antiseizure medication-induced cutaneous reactions in Brazil: A case-control study.
Spina Tensini T; de Paola L; Boldt ABW; Glehn CQCV; Bettinotti M; Silvado CES
HLA; 2023 Sep; 102(3):269-277. PubMed ID: 37002612
[TBL] [Abstract][Full Text] [Related]
7. Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population.
Ihtisham K; Ramanujam B; Srivastava S; Mehra NK; Kaur G; Khanna N; Jain S; Kumar S; Kaul B; Samudrala R; Tripathi M
Seizure; 2019 Mar; 66():99-103. PubMed ID: 30826555
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
Chung WH; Chang WC; Lee YS; Wu YY; Yang CH; Ho HC; Chen MJ; Lin JY; Hui RC; Ho JC; Wu WM; Chen TJ; Wu T; Wu YR; Hsih MS; Tu PH; Chang CN; Hsu CN; Wu TL; Choon SE; Hsu CK; Chen DY; Liu CS; Lin CY; Kaniwa N; Saito Y; Takahashi Y; Nakamura R; Azukizawa H; Shi Y; Wang TH; Chuang SS; Tsai SF; Chang CJ; Chang YS; Hung SI; ;
JAMA; 2014 Aug; 312(5):525-34. PubMed ID: 25096692
[TBL] [Abstract][Full Text] [Related]
9. The HLA-B*15:02 polymorphism and Tegretol
Chouchi M; Kaabachi W; Tizaoui K; Daghfous R; Aidli SE; Hila L
Rev Neurol (Paris); 2018 May; 174(5):278-291. PubMed ID: 29685430
[TBL] [Abstract][Full Text] [Related]
10. Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population.
Mortazavi H; Rostami A; Firooz A; Esmaili N; Ghiasi M; Lajevardi V; Amirzargar AA; Sheykhi I; Khamesipour A; Akhdar M
Dermatol Ther; 2022 May; 35(5):e15393. PubMed ID: 35187767
[TBL] [Abstract][Full Text] [Related]
11. Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020.
Tee CT; Abdullah NH; Kristummoonthy P; Lee CS
Med J Malaysia; 2022 Jul; 77(4):409-414. PubMed ID: 35902928
[TBL] [Abstract][Full Text] [Related]
12. Integrating real-world data in cost-effectiveness analysis of universal HLA-B*15:02 screening in Malaysia.
Chong HY; Lim KS; Fong SL; Shabaruddin FH; Dahlui M; Mei Lai PS; Ng CC; Chaiyakunapruk N
Br J Clin Pharmacol; 2023 Nov; 89(11):3340-3351. PubMed ID: 37294011
[TBL] [Abstract][Full Text] [Related]
13. An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
Chang WC; Hung SI; Carleton BC; Chung WH
Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):723-734. PubMed ID: 32510242
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced hypersensitivity syndrome caused by valproic acid as a monotherapy for epilepsy: First case report in Asian population.
Wu XT; Hong PW; Suolang DJ; Zhou D; Stefan H
Epilepsy Behav Case Rep; 2017; 8():108-110. PubMed ID: 29204346
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis.
Alfares I; Javaid MS; Chen Z; Anderson A; Antonic-Baker A; Kwan P
CNS Drugs; 2021 Feb; 35(2):161-176. PubMed ID: 33580477
[TBL] [Abstract][Full Text] [Related]
16. Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study.
Kim JY; Lee J; Ko YJ; Shin JY; Jung SY; Choi NK; Park BJ
PLoS One; 2013; 8(12):e83849. PubMed ID: 24391836
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population.
Chang CC; Ng CC; Too CL; Choon SE; Lee CK; Chung WH; Hussein SH; Lim KS; Murad S
Pharmacogenomics J; 2017 Mar; 17(2):170-173. PubMed ID: 26927288
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
19. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
Hochbaum M; Kienitz R; Rosenow F; Schulz J; Habermehl L; Langenbruch L; Kovac S; Knake S; von Podewils F; von Brauchitsch S; Hamacher M; Strzelczyk A; Willems LM
Epilepsy Behav; 2022 May; 130():108666. PubMed ID: 35339390
[TBL] [Abstract][Full Text] [Related]
20. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
Latha S; Choon SE
Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
